glp-1 and kidney disease the kidney: from physiology to pharmacology and outcomes in diabetes Real-World Evidence for GLP-1 Receptor
Description
Understanding the mechanism behind this side effect and practical management approaches can help optimize your treatment experience
Type 2 diabetes (T2D) is among the most prevalent chronic metabolic disorders worldwide - driven by insulin resistance, pancreatic dysfunction, obesity, and unhealthy lifestyles
Indias pharma industry is strong
The intestine has garnered attention as a target organ for developing new therapies for impaired glucose tolerance
A ruling by drug watchdog ICER that Novo and Eli Lillys weight-loss drugs are cost-effective could pave the way for new growth.
